CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Phapros Tbk PT is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Phapros Tbk PT
Lantai Dasar, Gedung RNI
Jl. Denpasar Raya Kav. DIII
Phone: +62 215762709p:+62 215762709 JAKARTA SELATAN, 12950  Indonesia Ticker: PEHAPEHA
Business Summary
PT Phapros Tbk is an Indonesia-based pharmaceutical company. The Company’s segments include OTC (Over the Counter), Ethical, OGB (generic drugs bearing) and Toll-in. Its OTC segment handles over-the-counter medicinal products. Its OTC products, apart from being sold in pharmacies, can be sold through grocery stores, stalls, or minimarts. Its OGB segment handles branded generic products (OGB) and the target market for this product is government institutions and hospitals. Its Ethical segment handles products sold by prescription and the target market for the ethical division is mainly hospitals and pharmacies in addition to other health institutions. Its Toll-in manufacturing segment handles requests for drug production orders from other pharmaceutical industries. The Company's medical devices include ACS MB Primary, ACS FB and FB PS, Primary Hip Stem, INASHUNT Semilunar Flushing, BoneFill Ortho, and NPC-STRIP G. It also operates a calibration laboratory.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202512/31/2024Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
3845 Electromedical and electrotherapeutic apparatus

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President Commissioner Johanes NanangMarjianto 45 12/13/2018 12/13/2018
President Director Barokah SriUtami 56 4/1/2016 4/1/2016
Director of Finance HeruMarsono 53 4/1/2016 4/1/2016
8 additional Officers and Directors records available in full report.

General Information
Number of Employees: 1,264 (As of 9/30/2025)
Outstanding Shares: 840,000,000 (As of 9/30/2025)
Stock Exchange: JAK
Fax Number: +62 215763910


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, February 3, 2026